Glaucoma is a major cause of blindness across the globe, primarily due to the death of specific eye cells known as retinal ganglion cells (RGCs).
Once these cells are lost, there’s no current treatment to bring them back.
However, a group of researchers from the Schepens Eye Research Institute of Mass Eye and Ear has made a significant breakthrough that might change this reality.
Turning Blood Cells into Eye Cells
The team has developed a method to transform stem cells found in blood into retinal ganglion cells. This approach is unique because it changes the environment within the eye, making it possible for these newly formed cells to move to the right place in the retina and survive there.
This research, although conducted on mice, holds great promise for future human treatments, as reported in their November 6th study published in the Proceedings of the National Academy of Sciences (PNAS).
Overcoming Migration Challenges
One of the big challenges in treating eye conditions with stem cell transplants is getting the cells to move to where they’re needed most. In the past, many transplanted cells would just stay put at the injection site.
To tackle this, the researchers focused on signaling molecules known as chemokines that can guide the neurons to their desired location in the retina.
They examined hundreds of these molecules and identified 12 that are unique to RGCs. Among these, they found one – stromal derived factor 1 – that was particularly effective in guiding cell migration and integration.
The Implications of This Research
Senior author Petr Baranov, MD, Ph.D., of Mass Eye and Ear and assistant professor of Ophthalmology at Harvard Medical School, expressed excitement over the potential of this method.
This approach of using chemokines to direct cell movement could not only restore vision in glaucoma patients but might also be applicable in treating other neurodegenerative conditions.
A Glimpse into the Future
This discovery marks a significant step forward in the field of regenerative medicine.
While there’s still a long way to go before this treatment becomes available for human use, it opens up new avenues for glaucoma therapy and possibly for other diseases that involve cell degeneration.
The research team’s success in modifying the eye’s microenvironment to promote cell integration and survival could pave the way for more effective treatments, offering hope to millions affected by this condition.
If you care about eye health, please read studies about how vitamin B may help fight vision loss, and MIND diet may reduce risk of vision loss disease.
For more information about eye disease, please see recent studies about how to protect your eyes from glaucoma, and results showing this eye surgery may reduce dementia risk.
The research findings can be found in PNAS.
Copyright © 2023 Knowridge Science Report. All rights reserved.
